CHU de Montpellier Hôpital Arnaud de Villeneuve

Montpellier 34295

0 studies enrolling now · 3 studies all time

What they study most

Extensive-stage Small-cell Lung Cancer, Heart Failure, Non-Small Cell Lung Cancer

Studies at this site

• Ifinatamab Deruxtecan (I-DXd) in Subjects With Pretreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC) — Running, not enrolling
• Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1) — Running, not enrolling
• Personalized CRT - MPP Post Approval Study — Completed